Today: 19 April 2026
Visa’s next stablecoin move: Stripe-owned Bridge to expand Visa cards to 100+ countries
6 March 2026
2 mins read

Visa’s next stablecoin move: Stripe-owned Bridge to expand Visa cards to 100+ countries

SAN FRANCISCO, March 5, 2026, 16:12 (PST)

Visa Inc (V.N) is ramping up its collaboration with Stripe’s stablecoin platform, Bridge, aiming to roll out stablecoin-linked Visa cards in over 100 countries spanning Europe, Asia Pacific, Africa, and the Middle East by year’s end. These cards are already operational in 18 markets, allowing users to tap stablecoin balances at more than 175 million Visa-accepting merchants. Some transactions even settle “on-chain” via Bridge’s partner, Lead Bank, according to the companies. Financial IT

Stablecoins are cryptocurrencies built for price stability, usually locked to the U.S. dollar at a 1:1 ratio. Visa is offering wallets a recognizable spending method for these tokens as it experiments with blockchain settlement to see if it can accelerate money transfers under the hood.

The push zeroes in on settlement, that critical moment when banks tied to a card transaction finalize who pays what. Here, “on-chain” settlement refers to moving that process onto a blockchain ledger, ditching the usual back-office routines for reconciliation.

Visa’s crypto lead Cuy Sheffield says the move is intended to “bring the speed, transparency and programmability of stablecoins directly into the settlement process.” Bridge chief executive and co-founder Zach Abrams describes the goal as letting companies “own their own financial stack.” Visa is also looking at possible future payment flows that could include support for assets issued by Bridge. Fintech Singapore

Visa is running a stablecoin settlement pilot that enables issuers and acquirers—banks serving cardholders and merchants—to settle transactions with Visa via stablecoins on certain blockchain networks. Lead Bank has joined the initiative. The project aims to find out if on-chain reconciliation can accelerate fund flows and streamline operations. For now, Visa is considering fresh settlement options, but hasn’t committed to a timeline.

Mastercard isn’t sitting out the stablecoin race. On Tuesday, the payments giant and SoFi unveiled a tie-up allowing SoFiUSD—the fintech’s stablecoin—to be used for settlement right across Mastercard’s network. Sherri Haymond, an executive at Mastercard, framed the agreement as a move to enable “trusted digital currencies” to operate “at global scale.” Payments Dive

Visa slipped 0.25% to $319.80 late in the U.S. session. Mastercard, on the other hand, edged 0.27% higher at $524.66.

Reuters reported last year that Visa and Bridge rolled out stablecoin-linked cards in a handful of Latin American countries, letting customers spend stablecoins while merchants receive fiat. Stripe picked up Bridge in 2025.

Still, these stablecoin-linked cards depend on regulators and banks approving the nuts and bolts: token issuance, custody, and anti-money-laundering checks. If a token slips its dollar peg—or if wallet providers get slapped with stricter rules—the rollout could stall, and scaling up settlement pilots gets tougher.

Visa still considers stablecoins a minor part of its overall operations. Back in January, Sheffield told Reuters that annualised stablecoin settlements on the Visa network were coming in at roughly $4.5 billion. That figure sits in stark contrast to the $14.2 trillion in payments the company processed last year.

Stock Market Today

  • Align Technology (ALGN) Valuation Update After Recent Share Price Rise
    April 18, 2026, 11:43 PM EDT. Align Technology (ALGN) shares have rebounded roughly 9.8% over the past month, trading near $190. Despite a 21.8% gain year-to-date, the stock is down 46.5% over three years, reflecting mixed long-term performance. Simply Wall St's valuation checks score ALGN 1 out of 6, signaling caution. A Discounted Cash Flow (DCF) model estimates fair value at $205.48, suggesting shares are about 7.5% undervalued-indicating current prices are close to intrinsic value rather than clearly cheap or expensive. The stock's price-to-earnings (P/E) ratio stands at 33.17, above the sector average, reflecting expectations of growth and risk. Investors should weigh recent momentum against historic declines and monitor valuations closely for shifts.

Latest article

Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

18 April 2026
Definium Therapeutics shares rose to $22.68 after Stifel and Piper Sandler initiated coverage with Buy ratings, citing late-stage trials of DT120, an LSD-based tablet for anxiety and depression. The company will host an investor day April 22 in New York to discuss upcoming Phase 3 data. DT120 is in four pivotal studies, with top-line results expected through 2026. Johnson & Johnson and Compass Pathways are advancing rival clinic-based psychiatric drugs.
Salesforce leadership breaks silence on Benioff ICE-joke backlash as AI fears bite
Previous Story

Salesforce leadership breaks silence on Benioff ICE-joke backlash as AI fears bite

CrowdStrike Holdings Stock Jumps on 2027 Forecast Beat Despite AI Fears
Next Story

CrowdStrike Holdings Stock Jumps on 2027 Forecast Beat Despite AI Fears

Go toTop